0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Lyophilized Biologics and Vaccines - Modality-Based Approaches (Paperback, Softcover reprint of the original 1st ed. 2015) Loot Price: R4,699
Discovery Miles 46 990
Lyophilized Biologics and Vaccines - Modality-Based Approaches (Paperback, Softcover reprint of the original 1st ed. 2015):...

Lyophilized Biologics and Vaccines - Modality-Based Approaches (Paperback, Softcover reprint of the original 1st ed. 2015)

Dushyant Varshney, Man Mohan Singh

 (sign in to rate)
Loot Price R4,699 Discovery Miles 46 990 | Repayment Terms: R440 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

This book provides a detailed account of the most recent developments, challenges and solutions to seamlessly advance and launch a lyophilized biologics or vaccine product, based on diverse modalities, ranging from antibodies (e.g., monoclonal, fused), complex biologics (e.g., antibody drug conjugate, PEGylated proteins), and vaccines (e.g., recombinant-protein based). The authors adeptly guide the reader through all crucial aspects, from biophysical and chemical stability considerations of proteins, analytical methods, advances in controlled ice nucleation and quality-by-design approaches, alternate drying technology, to latest regulatory, packaging and technology transfer considerations to develop a stable, safe and effective therapeutic protein, vaccine and biotechnology products. Lyophilized Biologics and Vaccines: Modality-Based Approaches is composed of four sections with a total of 17 chapters. It serves as a reference to all critical assessments and steps from early pre-formulation stages to product launch: Provides recent understanding of heterogeneity of protein environment and selection of appropriate buffer for stabilization of lyophilized formulations Details the latest developments in instrumental analysis and controlled ice nucleation technology Explains in-depth lyophilized (or dehydrated) formulation strategies considering diverse modalities of biologics and vaccines, including plasmid DNA and lipid-based therapeutics Details an exhaustive update on quality-by-design and process analytical technology approaches, illustrated superbly by case studies and FDA perspective Provides the latest detailed account of alternate drying technologies including spray drying, bulk freeze-drying and crystallization, supported exceptionally by case studies Provides a step-by-step guide through critical considerations during process scale-up, technology transfer, packaging and drug delivery device selection, for a successful lyophilization process validation, regulatory submission and product launch Chapters are written by one or more world-renowned leading authorities from academia, industry or regulatory agencies, whose expertise cover lyophilization of the diverse modalities of biopharmaceuticals. Their contributions are based on the exhaustive review of literature coupled with excellent hands-on experiences in laboratory or GMP setup, making this an exceptional guide to all stages of lyophilized or dehydrated product development.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: October 2016
First published: 2015
Editors: Dushyant Varshney • Man Mohan Singh
Dimensions: 235 x 155 x 22mm (L x W x T)
Format: Paperback
Pages: 401
Edition: Softcover reprint of the original 1st ed. 2015
ISBN-13: 978-1-4939-5568-8
Categories: Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 1-4939-5568-3
Barcode: 9781493955688

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners